The ACMD considered the drug naphyrone and related compounds that are sometimes sold under brand names like NRG-1. While the prevalence of naphyrone use is unknown, many websites that previously sold mephedrone now claim to sell naphyrone. However, test purchases found the branded product NRG-1 did not always contain naphyrone. There is limited information on naphyrone's pharmacology, but it may cause adverse heart, blood vessel, and psychiatric effects and even death in extreme cases. The ACMD worries that users seeking legal highs may actually purchase illegal drugs of varying potency, increasing overdose risk. The ACMD recommended scheduling naphyrone as a Class B drug and conducting an